Page last updated: 2024-08-18

arginine vasopressin and Edema, Cardiac

arginine vasopressin has been researched along with Edema, Cardiac in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukunami, M; Hori, M; Izumi, T; Matsuzaki, M	1
Czerwiec, F; Gheorghiade, M; Kambayashi, J; Niazi, I; Orlandi, C; Ouyang, J; Zampino, M	1
Cotter, G; Dittrich, HC; Gheorghiade, M; Metra, M; Milo-Cotter, O	1

Reviews

1 review(s) available for arginine vasopressin and Edema, Cardiac

Article	Year
Fluid overload in acute heart failure--re-distribution and other mechanisms beyond fluid accumulation. European journal of heart failure, 2008, Volume: 10, Issue:2 Topics: Arginine Vasopressin; Arteries; Disease Progression; Edema, Cardiac; Elasticity; Heart Failure; Humans; Kidney Failure, Chronic; Lung; Pulmonary Edema; Renin-Angiotensin System; Vascular Resistance; Vasodilator Agents; Water-Electrolyte Imbalance	2008

Article

Year

Fluid overload in acute heart failure--re-distribution and other mechanisms beyond fluid accumulation.

European journal of heart failure, 2008, Volume: 10, Issue:2

Topics: Arginine Vasopressin; Arteries; Disease Progression; Edema, Cardiac; Elasticity; Heart Failure; Humans; Kidney Failure, Chronic; Lung; Pulmonary Edema; Renin-Angiotensin System; Vascular Resistance; Vasodilator Agents; Water-Electrolyte Imbalance

2008

Trials

2 trial(s) available for arginine vasopressin and Edema, Cardiac

Article	Year
Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study). Cardiovascular drugs and therapy, 2011, Volume: 25 Suppl 1 Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Diuretics; Double-Blind Method; Edema, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged; Potassium; Sodium; Tolvaptan	2011
Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation, 2003, Jun-03, Volume: 107, Issue:21 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Chronic Disease; Diuretics; Double-Blind Method; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Osmolar Concentration; Sodium; Tolvaptan; Treatment Outcome; Urinalysis; Water-Electrolyte Balance	2003

Article

Year

Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study).

Cardiovascular drugs and therapy, 2011, Volume: 25 Suppl 1

Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Diuretics; Double-Blind Method; Edema, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged; Potassium; Sodium; Tolvaptan

2011

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.

Circulation, 2003, Jun-03, Volume: 107, Issue:21

Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Chronic Disease; Diuretics; Double-Blind Method; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Osmolar Concentration; Sodium; Tolvaptan; Treatment Outcome; Urinalysis; Water-Electrolyte Balance

2003